This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumas, C.
Right arrow Articles by Papadopoulou, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumas, C.
Right arrow Articles by Papadopoulou, B.

 Previous Article  |  Next Article 

Infection and Immunity, November 2003, p. 6499-6509, Vol. 71, No. 11
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.11.6499-6509.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Recombinant Leishmania major Secreting Biologically Active Granulocyte-Macrophage Colony-Stimulating Factor Survives Poorly in Macrophages In Vitro and Delays Disease Development in Mice

Carole Dumas, Anthony Muyombwe, Gaétan Roy, Claudine Matte,{dagger} Marc Ouellette, Martin Olivier,* and Barbara Papadopoulou*

Infectious Diseases Research Center, CHUL Research Center, Department of Medical Biology, Faculty of Medicine, Laval University, Quebec, Canada

Received 7 February 2003/ Returned for modification 8 April 2003/ Accepted 6 August 2003

Leishmania is an intracellular pathogen that replicates inside macrophages. Activated macrophages produce a specific subset of cytokines that play an important role in the control of Leishmania infections. As part of our interest in developing suicide parasites that produce abortive infections for the purposes of vaccination, we engineered recombinant Leishmania major strains producing biologically active granulocyte-macrophage colony-stimulating factor (GM-CSF). We showed that GM-CSF is being produced in the phagosomes of infected macrophages and that it can be detected in the culture supernatants of both infected macrophages and extracellular parasites. Our data support the notion that GM-CSF secreted by both developmental forms of recombinant L. major can activate macrophages to produce high levels of proinflammatory cytokines such as interleukin-1ß (IL-1ß), IL-6, and IL-18 and various chemokines including RANTES/CCL5, MIP-1{alpha}/CCL3, MIP-1ß/CCL4, MIP-2/CXCL2, and MCP-1/CCL2, which enhance parasite killing. Indeed, GM-CSF-expressing parasites survive poorly in macrophages in vitro and produce delayed lesion development in susceptible BALB/c mice in vivo. Selective killing of intracellular Leishmania expressing cytokine genes capable of activating cellular responses may constitute a promising strategy to control and/or prevent parasitic infections.

* Corresponding authors. Mailing address for B. Papadopoulou: Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Pavillon CHUL, 2705 boul. Laurier, Ste-Foy, Québec, Canada GIV 4G2. Phone: (418) 654-2705. Fax: (418) 654-2715. E-mail: barbara.papadopoulou{at}crchul.ulaval.ca. Present address for M. Olivier: Department of Medicine, Microbiology and Immunopathology, McGill University, Montreal, Quebec, Canada H3A 2B4. Phone: 514-398-5592. Fax: 514-398-7052. E-mail: martin.olivier@staff.mcgill.ca.

Editor: J. M. Mansfield

{dagger} Present address: Department of Microbiology and Immunology, University of Montreal, Montreal, Quebec, Canada.

Infection and Immunity, November 2003, p. 6499-6509, Vol. 71, No. 11
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.11.6499-6509.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Field, A. E., Wagage, S., Conrad, S. M., Mosser, D. M. (2007). Reduced Pathology following Infection with Transgenic Leishmania major Expressing Murine CD40 Ligand. Infect. Immun. 75: 3140-3149 [Abstract] [Full Text]  
  • Elshafie, A. I., Ahlin, E., Mathsson, L., ElGhazali, G., Ronnelid, J. (2007). Circulating Immune Complexes (IC) and IC-Induced Levels of GM-CSF Are Increased in Sudanese Patients with Acute Visceral Leishmania donovani Infection Undergoing Sodium Stibogluconate Treatment: Implications for Disease Pathogenesis. J. Immunol. 178: 5383-5389 [Abstract] [Full Text]  
  • Vasquez, R. E., Soong, L. (2006). CXCL10/Gamma Interferon-Inducible Protein 10-Mediated Protection against Leishmania amazonensis Infection in Mice. Infect. Immun. 74: 6769-6777 [Abstract] [Full Text]  
  • Breton, M., Tremblay, M. J, Ouellette, M., Papadopoulou, B. (2005). Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis. Infect. Immun. 73: 6372-6382 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»